Watchlist Price Alert

RedHill Biopharma Ltd. (RDHL)

NASDAQ: RDHL · Real-Time Price · USD

1.97

0.04 (2.07%)

At close: Jun 06, 2025, 3:56 PM

1.93

-1.78%

After-hours: Jun 06, 2025, 07:34 PM EDT

RedHill Biopharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	8.04M	6.51M	61.8M	85.76M	64.36M	6.29M	8.36M	4.01M	101K
Cost of Revenue	3.19M	3.46M	33.34M	49.41M	36.89M	2.26M	2.84M	2.13M	30.54M
Gross Profit	4.85M	3.05M	28.46M	36.35M	27.47M	4.03M	5.52M	1.88M	-30.44M
Operating Income	-14.61M	12.63M	-42.84M	-81.14M	-63.68M	-43.2M	-39.33M	-51.97M	-30.54M
Interest Income	133K	93.76K	140K	51K	270K	1.33M	678K	6.5M	1.55M
Pretax Income	-8.27M	23.92M	-71.67M	-97.74M	-76.17M	-42.3M	-38.82M	-45.54M	-29.37M
Net Income	-8.27M	23.92M	-59.24M	-114.31M	-89.02M	-43.63M	-38.82M	-45.54M	-29.37M
Selling & General & Admin	15.52M	30.98M	64.03M	87.99M	74.66M	29.81M	19.99M	20.04M	5.4M
Research & Development	1.59M	3.52M	7.28M	29.5M	16.49M	17.42M	24.86M	32.97M	25.24M
Other Expenses	2.36M	-44.06M	n/a	n/a	n/a	n/a	n/a	845K	n/a
Operating Expenses	19.46M	-9.56M	71.31M	117.49M	91.15M	47.23M	44.85M	53.85M	30.64M
Interest Expense	55K	367K	41.33M	16.57M	12.76M	438K	167K	77K	375K
Selling & Marketing Expenses	1M	2.1M	9.06M	11.38M	49.28M	18.33M	12.49M	12.01M	1.55M
Cost & Expenses	22.66M	-6.1M	104.64M	166.89M	128.04M	49.49M	47.69M	55.98M	30.64M
Income Tax Expense	n/a	n/a	-12.42M	16.57M	12.84M	1.33M	727K	6.29M	1.27M
Shares Outstanding (Basic)	12.32B	2.59B	619.3M	465.27M	364.28M	296.92M	231.2M	175.17M	123.72M
Shares Outstanding (Diluted)	12.32B	2.59B	619.3M	465.27M	364.28M	296.92M	231.2M	176.58M	128.81M
EPS (Basic)	-0.00	0.25	-46.29	-84.03	-83.64	-56.99	-67.16	-103.17	-91.41
EPS (Diluted)	-0.00	0.25	-46.29	-84.03	-83.64	-56.99	-67.16	-104	-94.96
EBITDA	-7.59M	26.27M	-42.84M	-63.03M	-54.94M	-40.78M	-38.6M	-45.79M	-30.5M
EBIT	-8.21M	24.28M	-30.34M	-81.18M	-63.72M	-41.91M	-38.82M	-45.54M	-30.54M
Depreciation & Amortization	619K	1.99M	8.12M	18.16M	8.81M	1.22M	89.71K	81.57K	44.14K